References
- Agha-Hosseini F, Moosavi MS, Sadrzadeh Afshar MS, Sheykhbahaei N. Assessment of the relationship between stress and oral lichen planus: a review of literature. J Islam Dent Assoc Iran. 2016; 28:78–85.
- Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar M-S. Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review. J Contemp Dent Pract. 2016; 17:692–701.
- Boorghani M, Gholizadeh N, Zenouz AT, Vatankhah M, Mehdipour M. Oral lichen planus: clinical features, etiology, treatment and management; a review of literature. J Dent Res Dent Clin Dent Prospect. 2010; 4:3–9. doi: 10.5681/joddd.2010.002
- Katne T, Muppirala AVS, Devaraju RR, Gantala R. A potent regimen for oral lichen planus: a review. Ann Essence Dentist. 2017; 9:7c–11c. doi: 10.5368/aedj.2017.9.2.3.2
- Yarnell E, Abascal K. Herbal treatment for lichen planus. Altern Complement Ther. 2010; 16:217–22.
- Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007; 28:521–74.
- Ahmed SA. The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology. 2000; 150:191–206.
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014; 12:1495–9.
- Seriolo B, Cutolo M, Garnero A, Accardo S. Relationships between serum 17 β-oestradiol and anticardiolipin antibody concentrations in female patients with rheumatoid arthritis. Rheumatology (Oxford). 1999; 38:1159–61.
- Tengstrand B, Carlström K, Felländer-Tsai L, Hafström I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol. 2003; 30:2338–43.
- Calabrese EJ. Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol. 2001; 31:503–15.
- Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999; 103:282–8.
- Verheul H, Schot L, Schuurs H. Therapeutic effects of nandrolone decanoate, tibolone, lynestrenol and ethylestrenol on Sjögren's syndrome-like disorder in NZB/W mice. Clin Exp Immunol. 1986; 64:243–8.
- MacKenzie-Graham AJ, Rinek GA, Avedisian A, Morales LB, Umeda E, Boulat B, et al. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis. J Neurosci Res. 2012; 90:1310–23.
- Vandenbroucke JP, Witteman JC, Valkenburg HA, Boersma JW, Cats A, Festen JJ, et al. Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA. 1986; 255:1299–303.
- Gholizadeh N, Poorfar HK, Taghavi Zenouz A, Vatandoost M, Mehdipour M. Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol. 2015; 10:136–40.
- Ansar Ahmed S, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect. 1999; 107(Suppl 5):681–6.
- Losordo DW, Isner JM. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol. 2001; 21:6–12.
- Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006; 1089:538–47.
- Rider V, Jones SR, Evans M, Abdou NI. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol. 2000; 95:124–34.
- Vohra S, Singal A, Sharma SB. Clinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial. Int J Dermatol. 2016; 55:101–5.